Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Cohlhepp Ryan
Over the trailing 90 days, Cohlhepp Ryan (Director at Bicara Therapeutics Inc.) traded $1.2M of stock (net selling $985K) in BCAX, per 10 SEC Form 4 transactions.
- Role
- Director
- Companies
- BCAX
- Window
- Trailing 90 days · 10 transactions · CIK 2034665
- Net activity
- −$985K ($101K bought · $1.1M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 10 | $101K | $1.1M | −$985K |
Transactions (10)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-09 | BCAX | Sell | 536 | $16K | Open market or private sale |
| 2026-07-08 | BCAX | Sell | 1.1K | $33K | Open market or private sale |
| 2026-07-08 | BCAX | Sell | 22.8K | $657K | Open market or private sale |
| 2026-07-08 | BCAX | Sell | 4.3K | $128K | Open market or private sale |
| 2026-07-08 | BCAX | Sell | 18.8K | $0 | Exercise or conversion of derivative security |
| 2026-07-08 | BCAX | Buy | 18.8K | $71K | Exercise or conversion of derivative security |
| 2026-05-15 | BCAX | Sell | 8.0K | $162K | Open market or private sale |
| 2026-05-15 | BCAX | Buy | 8.0K | $30K | Exercise or conversion of derivative security |
| 2026-05-15 | BCAX | Sell | 8.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-15 | BCAX | Sell | 4.5K | $91K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Cohlhepp's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.